143 related articles for article (PubMed ID: 36862966)
1. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
[TBL] [Abstract][Full Text] [Related]
2. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract][Full Text] [Related]
3. Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K; Kanagal-Shamanna R; Montalban-Bravo G; Assi R; Jabbour E; Ravandi F; Kadia T; Pierce S; Takahashi K; Nogueras Gonzalez G; Patel K; Soltysiak KA; Cortes J; Kantarjian HM; Garcia-Manero G
Cancer; 2020 Feb; 126(4):765-774. PubMed ID: 31742675
[TBL] [Abstract][Full Text] [Related]
4. Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies.
Stengel A; Baer C; Walter W; Meggendorfer M; Kern W; Haferlach T; Haferlach C
Blood Adv; 2021 Nov; 5(21):4426-4434. PubMed ID: 34570179
[TBL] [Abstract][Full Text] [Related]
5. Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients.
Lee WH; Lin CC; Tsai CH; Tseng MH; Kuo YY; Liu MC; Tang JL; Sun HI; Chuang YK; Chou WC; Hou HA; Tien HF
Am J Hematol; 2022 Dec; 97(12):1589-1598. PubMed ID: 36109871
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan-cancer cohort.
Xu E; Su K; Zhou Y; Gong L; Xuan Y; Liao M; Cao J; Li Y; Lu Y; Zhao Y; Chen F
J Cell Mol Med; 2021 Nov; 25(21):10279-10290. PubMed ID: 34658138
[TBL] [Abstract][Full Text] [Related]
7. Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
Ohgami RS; Ma L; Merker JD; Gotlib JR; Schrijver I; Zehnder JL; Arber DA
Mod Pathol; 2015 May; 28(5):706-14. PubMed ID: 25412851
[TBL] [Abstract][Full Text] [Related]
8. Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
Marshall CH; Gondek LP; Luo J; Antonarakis ES
Cancer Res; 2022 Nov; 82(22):4107-4113. PubMed ID: 36040522
[TBL] [Abstract][Full Text] [Related]
9. High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
Stonestrom AJ; Menghrajani KN; Devlin SM; Franch-Expósito S; Ptashkin RN; Patel SY; Spitzer B; Wu X; Jee J; Sánchez Vela P; Milbank JH; Shah RH; Mohanty AS; Brannon AR; Xiao W; Berger MF; Mantha S; Levine RL
Blood Adv; 2024 Feb; 8(4):846-856. PubMed ID: 38147626
[TBL] [Abstract][Full Text] [Related]
10. TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms.
Martínez-Avilés L; Besses C; Álvarez-Larrán A; Torres E; Serrano S; Bellosillo B
Ann Hematol; 2012 Apr; 91(4):533-41. PubMed ID: 21904853
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of splicing machinery genes SF3B1, U2AF1 and SRSF2 in myelodysplasia and other common tumors.
Je EM; Yoo NJ; Kim YJ; Kim MS; Lee SH
Int J Cancer; 2013 Jul; 133(1):260-5. PubMed ID: 23280334
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat.
Oppliger Leibundgut E; Haubitz M; Burington B; Ottmann OG; Spitzer G; Odenike O; McDevitt MA; Röth A; Snyder DS; Baerlocher GM
Haematologica; 2021 Sep; 106(9):2397-2404. PubMed ID: 32732354
[TBL] [Abstract][Full Text] [Related]
13. Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.
Vasseur D; Arbab A; Giudici F; Marzac C; Michiels S; Tagliamento M; Bayle A; Smolenschi C; Sakkal M; Aldea M; Sassi H; Dall'Olio FG; Pata-Merci N; Cotteret S; Fiévet A; Auger N; Friboulet L; Facchinetti F; Géraud A; Ponce S; Hollebecque A; Besse B; Micol JB; Italiano A; Lacroix L; Rouleau E
NPJ Precis Oncol; 2024 Feb; 8(1):51. PubMed ID: 38409229
[TBL] [Abstract][Full Text] [Related]
14. Biological background of the genomic variations of cf-DNA in healthy individuals.
Liu J; Chen X; Wang J; Zhou S; Wang CL; Ye MZ; Wang XY; Song Y; Wang YQ; Zhang LT; Wu RH; Yang HM; Zhu SD; Zhou MZ; Zhang XC; Zhu HM; Qian ZY
Ann Oncol; 2019 Mar; 30(3):464-470. PubMed ID: 30475948
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Brecqueville M; Rey J; Bertucci F; Coppin E; Finetti P; Carbuccia N; Cervera N; Gelsi-Boyer V; Arnoulet C; Gisserot O; Verrot D; Slama B; Vey N; Mozziconacci MJ; Birnbaum D; Murati A
Genes Chromosomes Cancer; 2012 Aug; 51(8):743-55. PubMed ID: 22489043
[TBL] [Abstract][Full Text] [Related]
16. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
[TBL] [Abstract][Full Text] [Related]
17. Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?
Vobugari N; Heuston C; Lai C
Clin Adv Hematol Oncol; 2022 Jun; 20(6):375-383. PubMed ID: 35731608
[TBL] [Abstract][Full Text] [Related]
18. Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome.
Wang H; Guo Y; Dong Z; Li T; Xie X; Wan D; Jiang Z; Yu J; Guo R
Sci Rep; 2020 Oct; 10(1):18622. PubMed ID: 33122737
[TBL] [Abstract][Full Text] [Related]
19. ASXL1 mutation in clonal hematopoiesis.
Fujino T; Kitamura T
Exp Hematol; 2020 Mar; 83():74-84. PubMed ID: 31945396
[TBL] [Abstract][Full Text] [Related]
20. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
